As the number of patients and SBRT dose increased, 1-year OS rates showed a trend of decrease.
← all excerpts
Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis.
2
—
—
The sentences
Heterogeneity analysis For the LAPC series, 1-year, 2-year and 3-year OS rates, 1-year PFS rate, the incidence rates of acute GI and hematologic toxicities (grade≥3) demonstrated significant or borderline significant heterogeneities among the studies.